Press release
Non-Alcoholic Steatohepatitis (NASH) Market Analysis, Trends, Growth, Research And Forecast 2033
Non-Alcoholic Steatohepatitis (NASH) Market
The Business Research Company offers in-depth market insights through Non Alcoholic Steatohepatitis NASH Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The non-alcoholic steatohepatitis (NASH) market size has grown exponentially in recent years. It will grow from $3.33 billion in 2023 to $4.54 billion in 2024 at a compound annual growth rate (CAGR) of 36.3%. The growth in the historic period can be attributed to rising prevalence of NASH, obesity epidemic, growing awareness and diagnoses, shift in lifestyle and dietary patterns, healthcare infrastructure development.
The non-alcoholic steatohepatitis (NASH) market size is expected to see exponential growth in the next few years. It will grow to $14.53 billion in 2028 at a compound annual growth rate (CAGR) of 33.7%. The growth in the forecast period can be attributed to advancements in NASH drug development, increasing NASH screening initiatives, rising healthcare expenditure, collaborative research efforts, government support and regulations. Major trends in the forecast period include focus on lifestyle interventions and patient education, increased collaboration in clinical research, regulatory advancements and pathway designations, integration of artificial intelligence in diagnosis and monitoring.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=8805&type=smp
Market Segmentation:
The non- alcoholic steatohepatitis (NASH) market covered in this report is segmented -
1) By Type: Solid, Liquid
2) By Product: Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib and Cenicriviroc, Other Products
3) By Disease Cause: Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity
4) By Sales Channel: Hospital Pharmacy, Retail Pharmacy, Online Provider
5) By Application: Oral, Parenteral
Major Driver - The Growing Demand For NASH Treatment Amid Obesity Epidemic
The rising cases of obesity is driving the demand for the non-alcoholic steatohepatitis (NASH) market going forward. Obesity is an aberrant or excessive fat build-up that poses a health concern, as well as body weight that is higher than what is deemed healthy or typical for a person of a specific height. As non-alcoholic fatty liver disease has become more prevalent due to the rising obesity pandemic, NASH may become the most widespread cause of severe liver disease in the ensuing decades, therefore, driving need for NASH treatment and related drugs. For instance, in April 2021, according to the COVID-19 and Obesity: The 2021 Atlas, a report published by the World Obesity Federation, a UK-based federation that represents professional members of the scientific 2021, percentage of overweight adults recorded more than 60% of the US population, however, the obesity percentage of male expected to reach 44.2% and female 44.4% by 2025 in the US population. Therefore, the rise in the cases of obesity will drive the growth of the Non-Alcoholic Steatohepatitis (NASH) market.
Competitive Landscape:
Major companies operating in the non-alcoholic steatohepatitis (NASH) market report are NGM Biopharmaceuticals Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline plc., F. Hoffmann-La Roche AG, The Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Novo Nordisk A/S, Genfit SA, Cadila Pharmaceuticals Ltd., Intercept Pharmaceuticals Inc., Enanta Pharmaceuticals Inc., Blade Therapeutics Inc., Cempra Pharmaceuticals Inc., Galmed Pharmaceuticals Inc., Immuron Limited, Terns Pharmaceuticals Inc., Tobira Therapeutics Inc., Arena Pharmaceuticals Inc., Vivus LLC, Arisaph Pharmaceuticals Inc., Galectin Therapeutics Inc., Raptor Pharmaceutical Inc., VERVA Technologies Pvt Ltd., Viking Therapeutics, Conatus Pharmaceuticals Inc., One Way Liver S.L., BioPredictive S.A.S., Madrigal Pharmaceuticals Inc., Cirius Therapeutics, Akero Therapeutics Inc., Echosens
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-nash-global-market-report
Top Trend - Unveiling Therapeutic Breakthroughs For NASH Treatment
Major companies in the non-alcoholic steatohepatitis (NASH) market are focusing on developing innovative product, such as a thyroid hormone receptor (THR)-β selective agonist designed to target key underlying causes of non-alcoholic steatohepatitis. The thyroid hormone receptor is a protein that, upon binding with thyroid hormones, regulates gene expression and plays a crucial role in various physiological processes. For instance, in July 2023, Madrigal Pharmaceuticals, Inc., a US-based clinical-stage biopharmaceutical company that develops and commercializes drugs, completed the submission of a New Drug Application seeking accelerated approval of Resmetirom for the treatment of NASH with liver fibrosis. This product, with key features such as once-daily oral therapy and liver-directed action, targets hepatic steatosis, inflammation, and hepatocellular injury in non-alcoholic steatohepatitis (NASH) with liver fibrosis. Its Breakthrough Therapy designation by the FDA and a comprehensive clinical development program, including Phase 3 trials, underscore its potential to address unmet medical needs, offering a promising advancement in the treatment landscape for NASH with liver fibrosis.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Non Alcoholic Steatohepatitis NASH Market Characteristics
3. Non Alcoholic Steatohepatitis NASH Market Trends And Strategies
4. Non Alcoholic Steatohepatitis NASH Market - Macro Economic Scenario
5. Non Alcoholic Steatohepatitis NASH Market Size And Growth
…..
27. Non Alcoholic Steatohepatitis NASH Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Alcoholic Steatohepatitis (NASH) Market Analysis, Trends, Growth, Research And Forecast 2033 here
News-ID: 3418824 • Views: …
More Releases from The Business research company
Future Prospects: Key Factors Shaping the Edge Print Servers for Data Centers Ma …
The edge print servers for data centers (DCs) market is poised for significant expansion as digital transformation and advanced printing needs rise across industries. With increasing reliance on edge computing and efficient print management, this market is set to experience rapid growth and technological innovation in the years ahead. Here is a detailed look at the market size, key players, segmentation, and emerging trends shaping this dynamic landscape.
Projected Market Growth…
Key Industry Players Strengthening Their Position In The Direct Coombs Test (DCT …
The Direct Coombs Test (DCT) antibody market is gaining significant traction as advancements in medical diagnostics and growing healthcare needs drive demand. With innovations enhancing testing accuracy and expanding applications across diverse medical fields, this market is set to experience substantial growth in the upcoming years. Let's explore the market's projected size, key players, trends shaping the industry, and how the market is segmented.
Direct Coombs Test (DCT) Antibody Market Size…
Global Trends Analysis: How The Dental Practice Analytics Dashboards Market Is R …
The dental practice analytics dashboards market is on track for significant expansion in the coming years, driven by the increasing use of data and technology in dental care management. As dental practices seek more efficient and patient-centered solutions, this market is set to grow rapidly, with new innovations and partnerships further enhancing its potential.
Projected Market Size and Growth for Dental Practice Analytics Dashboards
The market for dental practice analytics dashboards is…
Datacenters Market Structure, Emerging Trends, And Leading Player Insights
The datacenters market is on the verge of remarkable growth as digital transformation accelerates across multiple industries. Driven by cutting-edge technologies and changing business needs, this sector is set to expand rapidly in the coming years. Let's explore the current market size, the main companies involved, emerging trends, and the key segments shaping the future of datacenters globally.
Steady Growth Forecast for the Datacenters Market by 2029
The global datacenters market is…
More Releases for NASH
The Growing Demand For NASH Treatment Amid Obesity Epidemic: A Key Catalyst Acce …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Non-Alcoholic Steatohepatitis (NASH) Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for non-alcoholic steatohepatitis (NASH) has seen a considerable expansion in the past few years. Its value is expected to rise from $4.5 billion in 2024 to $6.06 billion in 2025, marking…
Nonalcoholic Steatohepatitis (NASH) Market Massive Growth opportunity Ahead
Introduction
Nonalcoholic Steatohepatitis (NASH) is an advanced form of nonalcoholic fatty liver disease (NAFLD) characterized by fat accumulation in the liver along with inflammation and liver cell damage. If left untreated, NASH can progress to fibrosis, cirrhosis, liver failure, or hepatocellular carcinoma. Closely tied to the global obesity and diabetes epidemic, NASH has become a major healthcare burden, with millions affected worldwide and no widely approved curative therapy to date.
The NASH…
Non Alcoholic Steatohepatitis (NASH) Market Size to Hit $21,879 Million by 2028 …
According to our experience research team, Non Alcoholic Steatohepatitis (NASH) Market was valued at USD 1,569 Million in 2021, and the global Non Alcoholic Steatohepatitis (NASH) industry is projected to reach a value of USD 21,879 Million by 2028, at a CAGR of 60.4% during the forecast period 2022-2028
The report is focused on gaining various Non Alcoholic Steatohepatitis (NASH) market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining…
NASH Market Insight and Landscape report
Report Snapshot:
NASH is one of the furthermost causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming years, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NASH vary across different country level. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their…
Nash releases debut EP 'She Don't Know'
London-based singer/songwriter Nash has released his debut EP She Don’t Know. Recorded at the legendary RAK Studios, She Don’t Know has the feel of 60s rock but with a modern twist, leaving the listener hooked throughout and wanting to come back for another listen. She Don’t Know’s leading single CK is an infectious number which is sure to be a hit for 2017.
Listening to the Beatles and Jack White growing…
Nash Technologies at GITEX/GULFCOMMS 2010
Harvey Nash subsidiary presents expert services to telecom operators in the Middle East, Africa and South Asia region
Nürnberg/Germany, 10th September 2010 – For the first time Nash Technologies will be present at GITEX/GULFCOMMS, the largest international trade event for mobile, fixed, IP and satellite communications for the Middle East, Africa and South Asia region, in Dubai from 17th to 21st October 2010 offering its telecom expert services. Nash Technologies will…
